RushNet Inc (OTCMKTS:RSHN) Stock In Focus After Agreement with Ehave for Mental Health Lab Testing
On Tuesday RushNet Inc (OTCMKTS:RSHN) announced that it had gone into an agreement with Ehave Inc for the purpose of laboratory testing in the mental health and psychedelic sectors. The company announced yesterday that it had inked a Memorandum of Understanding with Ehave, a digital therapeutics provider for the psychedelic and mental health sectors.
Trading Data
On Tuesday, RSHN stock ended flat at $0.0005 with more than 33.31 million shares, compared to its average volume of 12.05 million shares. The stock moved within a range of $0.0005 – 0.0007 after opening trade at $0.0005.
Rushnet, Inc Announces Agreement with Ehave for Mental Health Lab Testing
Ehave works on the development of laboratory testing solutions as well as healthcare data management for wellness and mental health sectors. RushNet subsidiary HeliosDX already has a Behavioral Toxicology Test in place which provides better visibility of patients’ health and hence, allows for faster diagnosis as well as treatment.
Both RushNet and Ehave have reached an agreement for the exploration of genetic testing for DNA biomarkers. Additionally, there would also be prescreening mental surveys of patients so that there is effective insight about the potential risk in adverse conditions to the patient when ketamine is used.
The prescreening will also provide insights in case of other psychedelics. In this regard, it should be noted that the agreement between the two companies is not only going to be limited to the current issues. In the future, the companies may also work on other conditions like Alzheimer’s.